Onat Yilmaz
Onat Yilmaz has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Asli Darcin
3 shared publicationsBaris Metin
3 shared publicationsNesrin Dilbaz
3 shared publicationsSehadet Ekmen
3 shared publications- Serdar Nurmedov
NPISTANBUL Neuropsychiatry Hospital, Istanbul, Turkey
3 shared publications Albert Espelt
2 shared publications
Latest Publications
- 28 August 2023
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (5) , 1232-1237
Effects of Disease Characteristics on the Sleep Quality in Sacrococcygeal Pilonidal Sinus Disease
- 28 August 2023
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (5) , 1232-1237
Effects of Disease Characteristics on the Sleep Quality in Sacrococcygeal Pilonidal Sinus Disease
- 1 October 2015
- Published by S. Karger AG in European Addiction Research
- Vol. 21 (6) , 327
Acknowledgement
- 1 October 2015
- Published by S. Karger AG in European Addiction Research
- Vol. 21 (6) , 327
Acknowledgement
- Open Access
- 1 October 2015
- Published by S. Karger AG in European Addiction Research
- Vol. 21 (6)
Contents Vol. 21, 2015
- 1 October 2015
- Published by S. Karger AG in European Addiction Research
- Vol. 21 (6)
Open AccessContents Vol. 21, 2015
- 28 May 2015
- Published by S. Karger AG in European Addiction Research
- Vol. 21 (6) , 315-320
Thalamic and Cerebellar Gray Matter Volume Reduction in Synthetic Cannabinoids Users
Background: Synthetic cannabinoids are compounds that bind cannabinoid receptors with a high potency and have been used widely in Europe by young people. However, little is known about the pharmacology and morphological effects of this group of substances in the brain. This study is aimed at investigating the morphological differences among synthetic cannabinoids users and healthy controls. Methods: Voxel-based morphometry was used to investigate the differences in brain tissue composition in 20 patients with synthetic cannabinoids use and 20 healthy controls. All participants were male. Results: Compared to healthy controls, voxel of interest analyses showed that regional grey matter volume in both left and right thalamus and left cerebellum was significantly reduced in synthetic cannabinoids users (p < 0.05). No correlation has been found between the age of first cannabis use, duration of use, frequency of use and grey matter volume. Discussion: These preliminary results suggest an evidence of some structural differences in the brain of synthetic cannabinoids users, and point the need for further investigation of morphological effects of synthetic cannabinoids in the brain.
- 28 May 2015
- Published by S. Karger AG in European Addiction Research
- Vol. 21 (6) , 315-320
Thalamic and Cerebellar Gray Matter Volume Reduction in Synthetic Cannabinoids Users
Background: Synthetic cannabinoids are compounds that bind cannabinoid receptors with a high potency and have been used widely in Europe by young people. However, little is known about the pharmacology and morphological effects of this group of substances in the brain. This study is aimed at investigating the morphological differences among synthetic cannabinoids users and healthy controls. Methods: Voxel-based morphometry was used to investigate the differences in brain tissue composition in 20 patients with synthetic cannabinoids use and 20 healthy controls. All participants were male. Results: Compared to healthy controls, voxel of interest analyses showed that regional grey matter volume in both left and right thalamus and left cerebellum was significantly reduced in synthetic cannabinoids users (p < 0.05). No correlation has been found between the age of first cannabis use, duration of use, frequency of use and grey matter volume. Discussion: These preliminary results suggest an evidence of some structural differences in the brain of synthetic cannabinoids users, and point the need for further investigation of morphological effects of synthetic cannabinoids in the brain.